Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cerevel Puts Tavapadon Into Phase III for Parkinson’s

Recruiting 1,200 Patients

Jan 15 2020

• By Kevin Grogan

Jigsaw — Tackling the Parkinson's disease puzzle • Source: Shutterstock

Related Content

Pfizer Exits Early Neuroscience, But M&A Could Allow Later Re-Entry

Jan 09 2018

Cerevel Launches With Pfizer's Early CNS Assets And $350m From Bain Capital

Oct 23 2018

Tony Coles's Yumanity Raises $45m To Treat Neurodegenerative Diseases

Feb 10 2016

Deal Watch: Pfizer, Biogen Partnership One Of Many As JPM Gets Underway

Jan 13 2020

Related Companies

Cerevel Therapeutics Holdings, Inc.

Pfizer Inc.

Biogen, Inc.

Yumanity Therapeutics, Inc.

Onyx Pharmaceuticals, Inc.

Amgen, Inc.

Additional Topics

Clinical Trials StartUps and SMEs Research & Development Neurology BioPharmaceutical

More from Neurological

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window